BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Loading...
Loading...

thrombotargets orphan drugs Pages on BioPortfolio:

BioPortfolio - thrombotargets orphan drugs
thrombotargets orphan drugs - BioPortfolio. ... Thrombotargets Corporation Receives Orphan Drug Designation from the U.S. Food and Drug Administration for
...
http://www.bioportfolio.com/search/thrombotargets_orphan_dru...

BioPortfolio - ThromboTargets Corporation
Thrombotargets Corp announced today that it has submitted its Orphan Drug Application of TT-103MH to the FDA for bleeding treatment in von Willebrand ...
http://www.bioportfolio.com/biocorporate/31064-Thrombo_Targe...

Thrombotargets Corp. Announces the Membership of Its New ...
Durham, North Caroline, June 1, 2007 - Thrombotargets Corp., a privately owned ... and drug candidates, specially TT-103MH, our Orphan Drug Designated ...
http://www.bioportfolio.com/biotech_news/Thrombotargets_6.ht...

Thrombotargets Corp. and Chemotargets to collaborate on ...
1 Jun 2007 ... TT-103MH, Thrombotargets’ most advanced drug candidate, has recently been granted with an Orphan Drug Designation. Contact: ...
http://www.bioportfolio.com/biotech_news/Thrombotargets_7.ht...

Thrombotargets Corporation announces the incorporation of Steven ...
TT-103MH, Thrombotargets’ most advanced drug candidate, has recently been granted with an Orphan Drug Designation, and will start Phase I clinical trials
in ...
http://www.bioportfolio.com/biotech_news/Thrombotargets_10.h...

BioPortfolio - Thrombotargets Development
Recent Search Terms used to find this page: Thrombotargets Development | thrombotargets contacts, durham | thrombotargets orphan drugs | Pharmaceutical .
...
http://www.bioportfolio.com/search/Thrombotargets_Developmen...

BioPortfolio - thrombotargets
BioPortfolio - thrombotargets orphan drugs thrombotargets orphan drugs ... Thrombotargets Corporation Announced it has submitted its Orphan Drug
Application ...
http://www.bioportfolio.com/search/thrombotargets.html...

BioPortfolio Biotechnology and Pharmaceutical News April to June 2007
Thrombotargets Corporation Receives Orphan Drug Designation from the U.S. Food and Drug Administration for its Procoagulant Agent, TT-103MH, ...
http://www.bioportfolio.com/biotech_news/april_to_june_2007....

BioPortfolio - pipeline drugs antifibrinolytic
Thrombotargets is an innovative drug discovery and development group of biotech . ... Maybe create and FDA website for super-orphan drugs information for ...
http://www.bioportfolio.com/search/pipeline_drugs_antifibrin...

BioPortfolio - orphan drugs consultants
1 Jun 2007 ... the Scientific Consultant Assistant of Thrombotargets Corp. ... and drug candidates, specially TT-103MH, our Orphan Drug Designated . ...
http://www.bioportfolio.com/search/orphan_drugs_consultants....

Results from other life science and pharmaceutical sites:

BioPortfolio - thrombotargets orphan drugs
thrombotargets orphan drugs - BioPortfolio. ... Thrombotargets Corporation Receives Orphan Drug Designation from the U.S. Food and Drug Administration for
...
http://www.bioportfolio.com/search/thrombotargets_orphan_dru...

BioSpace offers Pharmaceutical, Biotechnology and Healthcare ...
Asians Prone to Bleeding with Anti-Clotting Drugs 9/13/2007 More. ... Thrombotargets Corporation Announced it has submitted its Orphan Drug
Application to ...
http://www.biospace.com/news_by_disease_results.aspx?TheRxId...

BioPortfolio - ThromboTargets Corporation
Thrombotargets Corp announced today that it has submitted its Orphan Drug Application of TT-103MH to the FDA for bleeding treatment in von Willebrand ...
http://www.bioportfolio.com/biocorporate/31064-Thrombo_Targe...

List of Orphan Products Designa
230, Antiepilepsirine, Treatment of drug resistant generalized tonic-clonic ...... 10/11/07, Thrombotargets Corp. 2530 Meridian Parkway, Durham NC 27713 ...
http://www.fda.gov/orphan/designat/list.xls...

Thrombotargets Corp. Announces the Membership of Its New ...
Durham, North Caroline, June 1, 2007 - Thrombotargets Corp., a privately owned ... and drug candidates, specially TT-103MH, our Orphan Drug Designated ...
http://www.bioportfolio.com/biotech_news/Thrombotargets_6.ht...

Cumulative List of All Orphan Designated and or
Trade Name: drugs. Enbrel Orphan Designation: ...... Marketing Exclusivity Thrombotargets Corp. 2530 Meridian Parkway. Durham NC 27713 ...
http://www.fda.gov/Orphan/designat/alldes.rtf...

Thrombotargets Corp. and Chemotargets to collaborate on ...
1 Jun 2007 ... TT-103MH, Thrombotargets’ most advanced drug candidate, has recently been granted with an Orphan Drug Designation. Contact: ...
http://www.bioportfolio.com/biotech_news/Thrombotargets_7.ht...

BioSpace Life Sciences Company Profiles by Industry Segment
AOP Orphan Pharmaceuticals AG · Apex Bioscience, Inc. Apogee Biodimensions .... Faustus Forschung Translational Drug Development AG ...
http://www.biospace.com/company_segment.aspx?SegmentId=38919...

Google Custom Search

Search
  

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo